Skip to main content

Table 7 Significant effects of poly-miRTS on RFS of AML patients by univariate and multivariate Cox regression analysis

From: Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients

Genotype

Mean ± SE (day)

P

HR (95% CI)

P a

HR (95% CI)a

rs10786736

 GG

925 ± 113

 

1.00 (reference)

 

1.00 (reference)

 CC

892 ± 146

0.722

0.851 (0.350–2.070)

0.926

0.959 (0.393–2.342)

 CG

1267 ± 10

0.032

0.523 (0.289–0.946)

0.026

0.507 (0.279–0.921)

 CC+CGb

1214 ± 99

0.050

0.577 (0.333–1.000)

0.049

0.574 (0.331–0.997)

 CC+GGc

912 ± 97

0.034

1.855 (1.047–3.287)

0.022

1.957 (1.101–3.478)

rs3734703

 CC

1325 ± 96

 

1.00 (reference)

 

1.00 (reference)

 AA

592 ± 157

0.000

4.257 (1.936–9.360)

0.000

4.615 (2.086–10.209)

 CA

921 ± 123

0.014

2.158 (1.169–3.984)

0.032

1.955 (1.058–3.611)

 AA+CAb

815 ± 113

0.001

2.544 (1.446–4.478)

0.003

2.357 (1.337–4.155)

rs8139

 TT

1088 ± 150

 

1.00 (reference)

 

1.00 (reference)

 CC

834 ± 172

0.122

1.801 (0.855–3.796)

0.175

1.677 (0.794–3.541)

 CT

1182 ± 100

0.482

0.789 (0.408–1.526)

0.249

0.673 (0.343–1.319)

 CC/CT

 

0.015

2.282 (1.174–4.435)

0.007

2.537 (1.295–4.970)

 TT+CTd

1176 ± 86

0.018

2.105 (1.134–3.907)

0.015

2.172 (1.162–4.059)

  1. Italic values indicate statistical significance
  2. aAdjusted for risk stratifications
  3. bThe dominant model
  4. cThe overdominance model
  5. dThe recessive model